EDGAR Filing Documents for 0001213900-07-001220

Form 8-K - Current report:

SEC Accession No. 0001213900-07-001220

Filing Date

2007-09-13

Accepted

2007-09-13 15:37:18

Documents

Period of Report

2007-09-10

Items

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k091307_transdel.htm	8-K	31604
2	AMMENDED AND RESTATED CERTIFICATE OF INCORPORATION	f8k091307ex31_transdel.htm	EX-31.1	25519
3	AMMENDED AND RESTATED BYLAWS	f8k091307ex32_transdel.htm	EX-32.1	237060
	Complete submission text file	0001213900-07-001220.txt		295850

Mailing Address 300 PARK AVENUE SUITE 1700 NEW YORK NY 10022

Business Address 300 PARK AVENUE SUITE 1700 NEW YORK NY 10022 732-409-1212

TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 333-135970 | Film No.: 071115506
SIC: 1400 Mining & Quarrying of Nonmetallic Minerals (No Fuels)